Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048125 · ClinicalTrials.gov registry record · NA
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01048125: Clinical Trial NA study, sponsored by University of Missouri-Columbia.
NCT01048125 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01048125, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversible myocardial dysfunction predominantly affecting the apical and mid left ventricular segments. In this institution over the last two to three years the investigators have identified more than a dozen patients with stress cardiomyopathy. The investigators' overarching goal is to characterize these individuals with the hope of identifying risk factors and developing strategies to prevent the occurrence of SC in situations where the likelihood in susceptible individuals may be high.
Interventions
- DEVICE Sympathetic Nerve Activity
- BEHAVIORAL Mental Stress Test (Color Word Test)
- DRUG The Modified Oxford Technique for Baroreflex Sensitivity
- OTHER Cold Pressor Test
- DEVICE Echocardiographic evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-07 |
| Phase | NA |
Why NCT01048125 stopped before completion
NCT01048125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Sympathetic Nerve Activity is the first listed.
NCT01048125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01048125 about?
NCT01048125 is a clinical study titled "Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy". Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversible myocardial dysfunction predominantly affecting the apical and mid left ventricular segments. In this institution over the last two to three years the investigators have identified more than a dozen patients with stress c...
What is the current status of trial NCT01048125?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-08. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01048125?
The interventions under investigation include: Sympathetic Nerve Activity (DEVICE), Mental Stress Test (Color Word Test) (BEHAVIORAL), The Modified Oxford Technique for Baroreflex Sensitivity (DRUG), Cold Pressor Test (OTHER), Echocardiographic evaluation (DEVICE).
Who is sponsoring clinical trial NCT01048125?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01048125's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia